✦ LIBER ✦

Secukinumab efficacy in moderate to severe psoriasis appears not to be affected by previous biologic use: Results of a phase II, dose-ranging trial

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secukinumab efficacy in moderate to seve

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Secukinumab efficacy and safety outcomes

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Efficacy and safety of secukinumab in th

✍ Papp, K.A.; Langley, R.G.; Sigurgeirsson, B.; Abe, M.; Baker, D.R.; Konno, P.; H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Efficacy and safety results of secukinum

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB